Arch Gen Psychiatry -- Abstract: Trajectories of Depression Severity in Clinical Trials... - 0 views
-
Nathan Goodyear on 10 Dec 11amazingly, up to 20% of patents with depression do worse on anti-depressant therapy (SSRI). These are labeled non-responders, but when compared to placebo, the difference was significant. Maybe, we should check their neurotransmitters first?